Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation

International Journal of Radiation Oncology Biology Physics

Volumn 38, Issue 5, 1997, Pages 1071-1077

  Lim Joon, Daryl ^a,b   Hasegawa, Masatoshi ^a,c   Sikes, Charles ^a   Khoo, Vincent S ^a   Terry, Nicholas H A ^a   Zagars, Gunar K ^a   Meistrich, Marvin L ^a   Pollack, Alan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

Androgen ablation; Apoptosis; Prostate cancer; Radiation

Indexed keywords

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL KILLING; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; HIGH RISK POPULATION; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION RESPONSE; RAT; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; APOPTOSIS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; MALE; NEOPLASMS, HORMONE-DEPENDENT; ORCHIECTOMY; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RATS; TIME FACTORS;

EID: 0030805690     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00303-9     Document Type: Article

References (28)

1. Berges, R. R.; Vukanovic, J.; Epstein, J. I.; CarMichel, M.; Cisek, L.; Johnson, D. E.; Veltri, R. W.; Walsh, P. C.; Isaacs, J. T. Implication of cell kinetic changes during progression of human prostatic cancer. Clin. Cancer Res. 1:473-480; 1995.
2. Bolla, M.; Gonzalez, P.; Warde, P.; Dubois, J. B.; Mirimanoff, R.; Storme, G.; Bernier, J.; Kuten, A.; Sternberg, C.; Mattelaer, J.; Lopez Torrecilla, J.; Pfeffer, R.; Cutajar, C. L.; Pierart, M.; Collette, L.; Gil, T.; Bartelink, H.; and the EORTC Radiotherapy Cooperative Group. Immediate hormonal therapy improves locoregional control and survival in patients with locally advanced prostate cancer. Results of a Phase III clinical trial of the EORTC radiotherapy and genitourinary tract cancer cooperative groups. Proc. Am. Soc. Clin. Ocol. 15:591; 1996.
3. English, H. F.; Kyprianou, N.; Isaacs, J. T. Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration. Prostate 15:233-250; 1989.
4. Gallee, M. P. W.; van Steenbrugge, G.-J.; ten Kate,-F. J. W.; Schroeder, F. H.; van der Kwast, T. H. Determination of the proliferative fraction of a transplantable, hormone-dependent, human prostatic carcinoma (PC-82) by monoclonal antibody Ki-67: Potential application for hormone therapy monitoring. J. Natl. Cancer Inst. 79:1333-1340; 1987.
5. Gorczyca, W.; Gong, J.; Darzynkiewicz, Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1945-1951; 1993.
6. Little, J. B. Factors influencing the repair of potentially lethal radiation damage in growth-inhibited human cells. Radiat. Res. 56:320-333; 1973.
7. Meistrich, M. L.; Wilson, G.; Ye, W.-S; Thrash, C.; Huhtaniemi, I. Relationship among hormonal treatments, suppression of spermatogenesis and testicular protection from chemotherapy-induced damage. Endocrinology 137:3823-3831; 1996.
8. Meyn, R. E.; Stephens, L. C.; Ang, K. K.; Hunter, N. R.; Brock, W. A.; Milas, L.; Peters, L. J. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int. J. Radiat. Biol. 64:583-591; 1993.
9. Meyn, R. E.; Stephens, L. C.; Hunter, N. R.; Ang, K. K.; Milas, L. Reemergence of apoptotic cells between fractionated doses in irradiated murine tumors. Int. J. Radiat. Oncol. Biol. Phys. 30:619-624; 1994.
10. Milas, L.; Hunter, N. R.; Mason, K. A.; Kurdoglu, B.; Peters, L. J. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res. 54:3506-3510; 1994.
11. Milas, L.; Ito, H.; Hunter, N. R.; Jones, S.; Peters, L. J. Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: Dependency on tumor type. Cancer Res. 46:723-727; 1986.
12. Nakfoor, B. M.; Prince, E. A.; Shipley, W. U.; Zietman, A. L. A randomized trial comparing local tumor control following irradiation alone vs. combined androgen withdrawal and irradiation in an androgen sensitive prostate cancer xenograft ( Abst. 97) Int. J. Radiat. Oncol Biol. Phys. 32(Suppl 1):189; 1995.
13. Oomens, E. H. G. M.; van Steenbrugge, G. J.; van der Kwast, Th. H.; Schreder, F. H. Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the proliferative cell fraction of human prostatic carcinoma. J. Urol. 145:81-85; 1991.
14. Parchuri, N.; Wilson, G.; Meistrich, M. L. Protection of gonadal steroid hormones against procarbazine-induced damage to spermatogenic function in LBF1 hybrid rats. J. Androl. 14:257-266; 1993.
15. Pilepich, M. V.; Caplan, R.; Byhardt, R. W.; Lawton, C. A.; Gallagher, M. J.; Mesic, J. B.; Hanks, G. E.; Coughlin, C. T.; Porter, A.; Shipley, W. U.; Grignon, D. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of the Radiation Therapy Oncology Group protocol 85-31. J. Clin. Ocol. 15:1013-1021; 1997.
16. Pilepich, M. V.; Krall, J. M.; Al-Sarraf, M.; John, M. J.; Doggett, R. L. S.; Saise, W. T.; Lawton, C. A.; Abrams, R. A.; Rotman, M.; Rubin, P.; Shipley, W. U.; Grignon, D.; Caplan, R.; Cox, J. D. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group. Urology 45:616-623; 1995.
17. Pollack, A.; Block, N. L.; Stover, B. J.; Irvin, G. L., III; Fuentes, M. P.; Claflin, A. J.; Malinin, T. I. In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: Diethylstilbestrol diphosphate treatment vs. orchiectomy. J. Natl. Cancer Inst. 70:907-914; 1983.
18. Pollack, A.; Irvin, G. L.; Block, N. L.; Lipton, R. M.; Stover, B. J.; Claflin, A. J. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: Growth rate, DNA content, and hormone receptors. Cancer Res. 42:2184-2190; 1982.
19. Pollack, A.; Lim Joon, D.; Wu, C. S.; Sikes, C.; Hasegawa, M.; Terry, N. H. A.; White, R. A.; Zagars, G. K.; Meistrich, M. L. Quiescence in R3327-G rat prostate tumors after androgen ablation. Cancer Res. (in press).
20. Pollack, A.; Zagars, G. K.; Kopplin, S. Radiotherapy and androgen ablation for clinically localized high-risk prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:13-20; 1995.
21. Sands, M. E.; Pollack, A.; Zagars, G. K. Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation. Int. J. Radiat. Oncol. Biol. Phys. 31:13-19; 1995.
22. Soloway, M. S.; Sharifi, R.; Wajsman, Z.; McLeod, D.; Wood, D. P.; Puras-Baez, A.; for the Lupron depot neoadjuvant prostate cancer group. Randomized prospective study comparing radical prostatectomy alone vs. radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxMO) prostate cancer. J. Urol. 154:424-428; 1995.
23. Stephens, L. C.; Hunter, N. R.; Ang, K. K.; Milas, L.; Meyn, R. E. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat. Res. 135:75-80; 1993.
24. vanWeerden, W. M.; van Kreuningen, A.; Elissen, N. M. J.; de Vermeij, M.; Jong, F. H.; van Steenbrugge, G. J.; Schrder, F. H. Castration-induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice. Prostate 23:149-164; 1993.
25. Westin, P.; Bergh, A.; Damber, J.-E. Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate but not in the highly differentiated Dunning R-3327PAP prostatic adenocarcinoma. Prostate 22:65-74; 1993.
26. Westin, P.; Stattin, P.; Damber, J.-E.; Bergh, A. Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Am. J. Pathol. 146:1368-1375; 1995.
27. Zagars, G. K.; Johnson, D. E.; von Eschenbach, A. C.; Hussey, D. H. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: Long term results of a prospective randomized study. Int. J. Radiat. Oncol. Biol. Phys. 14:1085-1091; 1988.
28. Zietman, A. L.; Nakfoor, B. M.; Prince, E. A.; Gerweck, L. E.; Shipley, W. U. The effect of androgen deprivation on an androgen sensitive tumor: An in vitro and in vivo study. Cancer J. Sci. Am. 3:31-36; 1977.